Introduction of biosimilar insulins in Europe von Davies, M., Dahl, D., Heise, T., Kiljanski, J., Mathieu, C.

Volltext

Biosimilar insulins: a European perspective von DeVries, J. H., Gough, S. C. L., Kiljanski, J., Heinemann, L.

Volltext

Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exena... von Schernthaner, G., Rosas-Guzmán, J., Dotta, F., Guerci, B., Simó, R., Festa, A., Kiljański, J., Zhou, M., Gallwitz, B.

Volltext

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries von Ostenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Bruhn, David, Mathieu, Chantal, Theodorakis, Michael

Volltext

Introduction of biosimilar insulins in Europe von Davies, M, Dahl, D, Heise, T, Kiljanski, J, Mathieu, C

Volltext

PDB49 Resource Use in Patients with Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy: 6-Month Data from Choice von Theodorakis, M, Reaney, M.D, Bruhn, D, Matthaei, S, Mathieu, C, Kiljanski, J, Guerci, B, Sapin, H, Östenson, C.G, Salaun-Martin, C, Krarup, T

Volltext

Biosimilar insulins: a E uropean perspective von DeVries, J. H., Gough, S. C. L., Kiljanski, J., Heinemann, L.

Volltext

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study von Reaney, Matthew, Mathieu, Chantal, Ostenson, Claes-Göran, Matthaei, Stephan, Krarup, Thure, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael, Guerci, Bruno

Volltext

Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy : Should Graves' disease be considered a collagen diso... von KILJANSKI, J. I, PEELE, K, STACHURA, I, PICKERAL, J, STOLARSKI, C, KENNERDELL, J. S, WALL, J. R

Volltext

PDB8 FACTORS ASSOCIATED WITH THE CHOICE OF FIRST INJETABLE THERAPY AND 6-MONTH TREATMENT OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES: DATA FROM THE CHOICE STUDY IN GERMANY von Reaney, M, Matthaei, S, Kiljanski, J, Arellano, J, Nicolay, C

Volltext

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study von Kiiskinen, Urpo, Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Ostenson, Claes-Göran, Krarup, Thure, Theodorakis, Michael, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Guerci, Bruno

Volltext

Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE von Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael

Volltext

Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study von Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Petto, Helmut, Bruhn, David, Theodorakis, Michael

Volltext

Should Graves' Disease be Considered a Collagen Disorder of the Thyroid, Skeletal Muscle and Connective Tissue? von Kiljanski, J., Nebes, Vicki, Stachura, Irene, Kennerdell, J. S., Wall, J. R.

Volltext

Serum Antibodies Reactive with Eye Muscle Antigens and the TSH Receptor in a Euthyroid Subject Who Developed Ophthalmopathy and Graves' Hyperthyroidism von Wall, J, Barsouk, A, Stolarski, C, Kiljanski, J, Stachura, I, Nebes, V, Peele, K, Volpe, R, Kennerdell, J

Volltext

Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopat... von KILJANSKI, J, STOLARSKI, C, BARSOUK, A, NEBES, V, WALL, J. R

Volltext

Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders ; close relationship between serum cytotoxic a... von BARSOUK, A, PEELE, K. A, KILJANSKI, J, STOLARSKI, C, NEBES, V, KENNERDELL, J. S, VOLPE, R, WALL, J. R

Volltext

Association of G-174C Polymorphism of the Interleukin-6 Gene Promoter with Graves' Ophthalmopathy von Bednarczuk, Tomasz, Kury owicz, Alina, Hiromatsu, Yuji, Kilja ski, Jacek, Telichowska, Anna, Nauman, Janusz

Volltext

RESOURCE USE IN PATIENTS WITH TYPE 2 DIABETES (T2D) WHO INITIATED EXENATIDE BID (EXBID) OR STARTER INSULIN (INS) THERAPY: 6-MONTH DATA FROM CHOICE von Theodorakis, M, Reaney, MD, Bruhn, D, Matthaei, S, Mathieu, C, Kiljanski, J, Guerci, B, Sapin, H, Ostenson, CG, Salaun-Martin, C, Krarup, T

Volltext

Role of the Eye Muscles in Thyroid Eye Disease: Identification of the Principal Autoantigens von Gunji, K, Kubota, S, Swanson, J, Kiljanski, J, Bednarczuk, T, Wengrowicz, S, Salvi, M, Wall, J R

Volltext